[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352122-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352122-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unconventional-guardians-of-the-brain-mait-cells-as-emerging-players-in-glioblastoma-immunity","Unconventional guardians of the brain: MAIT cells as emerging players in glioblastoma immunity","","Glioblastomas (GBM) are aggressive brain cancers with limited curative options, and current T cell therapies face major barriers from the immunosuppressive tumour microenvironment and a shortage of tumour antigen-specific targets. This review examines the immune response to GBM and highlights mucosal-associated invariant T (MAIT) cells as resident brain immune populations with potential roles in anti-tumour surveillance and immunotherapy. Conflicting findings and unresolved MAIT–tumour interaction questions are addressed, emphasizing MAIT cells as possible novel therapeutic targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unconventional-guardians-of-the-brain-mait-cells-as-emerging-players-in-glioblastoma-immunity/352122/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unconventional-guardians-of-the-brain-mait-cells-as-emerging-players-in-glioblastoma-immunity/352122.png","ImageObject",300,407,{"name":42,"@type":43},"LangkahRina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are effective GBM treatments difficult to achieve?","Question",{"text":63,"@type":64},"Standard GBM therapy is largely ineffective at preventing recurrence, largely due to the immunosuppressive tumour microenvironment and the limited availability of tumour antigen-specific targets for immune therapies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the role of MAIT cells in GBM immunity according to the review?",{"text":68,"@type":64},"MAIT cells are described as resident brain immune populations that may contribute to critical immune surveillance and diverse anti-tumour functions, making them candidates for immunotherapeutic targeting.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the review say about the evidence for MAIT cells in cancer?",{"text":72,"@type":64},"Findings on the role of MAIT cells in cancer are reported as conflicting, and many questions about MAIT–tumour cell interactions remain unresolved.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352122,1790536572,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Review  \nPUBLISHED 13 August 2026  \nDOI 10.3389/fimmu.2026.1896626  \nOPEN ACCESS  \nEDITED BY  \nJordana Grazziela Coelho-dos-Reis, Federal University of Minas Gerais, Brazil  \nREVIEWED BY  \nMichele Caraglia,  \nUniversity of Campania Luigi Vanvitelli, Italy  \nHao Wu,  \nThe second afﬁliated hospital of Xi’an Medical University, China  \n*CORRESPONDENCE  \nAlexandra J. Corbett  \n [corbetta@unimelb.edu.au](corbetta@unimelb.edu.au)  \nRECEIVED 01 June 2026  \nREVISED 24 July 2026  \nACCEPTED 30 July 2026  \nPUBLISHED 13 August 2026  \nCITATION  \nEddy EM, Patton T, Barrow AD and Corbett AJ (2026) Unconventional guardians of the brain: MAIT cells as emerging players in glioblastoma immunity.  \nFront. Immunol. 17:1896626 .  \ndoi: 10.3389/fimmu.2026.1896626  \nCOPYRIGHT  \n© 2026 Eddy, Patton, Barrow and Corbett. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUnconventional guardians of the brain: MAIT cells as emerging players in glioblastoma immunity  \nEleanor M. Eddy, Timothy Patton, Alexander D. Barrow and Alexandra J. Corbett*  \nDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia  \nGlioblastomas (GBM) are an aggressive form of brain cancer with no curative treatment options. While T cell therapies have demonstrated substantial success in combatting blood cancers, their application for solid tumours, including GBM, is hampered by the immunosuppressive tumour microenvironment and scarcity of tumour antigen-speciﬁc targets. There is an urgent need to better understand the immune response to GBM to enable the development of new therapeutic approaches. Recently, a resident population of mucosal-associated invariant T (MAIT) cells in the brain has been described, which may perform critical immune surveillance functions. Recent research also suggests that MAIT cells play diverse roles in anti-tumour immunity, and there is much interest in exploring the potential of MAIT cells in immune therapy by harnessing their cytotoxic capacity and tissue homing properties. However, ﬁndings on the role of MAIT cells in cancer are conﬂicting, while many basic questions regarding MAIT-tumour cell interactions remain. Here we review the challenges for GBM treatment, as well asthe potential of unconventional T cells in cancer immunotherapy, with a focus on MAIT cells, their potential role in cancer, and their suitability as novel therapeutic targets in solid tumours such as GBM.  \nKEYWORDS  \nbrain, GBM, glioblastoma, immune therapy, MAIT cells  \nIntroduction: glioblastoma overview and challenges  \nGliomas as a group account for over 80% of all malignant brain tumours and encompass both high-grade malignancies and low-grade tumours (1) . Glioblastomas (GBMs) are classiﬁed by the World Health Organisation (WHO) as high grade (grade IV) gliomas. Recently, GBM nomenclature has been updated by the WHO to include molecular markers including isocitrate dehydrogenase (IDH) mutation status, categorising GBM tumours as IDH-wildtype or IDH-mutant (2) . IDH mutations correlate with an improved chance survival of survival, however, a majority of GBM tumours are IDH-wildtype (3) .  \nGBM is a relatively rare cancer, affecting approximately 7 individuals per 100,000 people in western populations (4, 5) . However, GBM accounts for approximately half of malignant brain tumours, and exhibits disproportionately high mortality rates – the median survival time of 15 months from diagnosis (6), and a 5-year survival rate of 4.6%, which is markedly lower than other brain cancer types averagin","cbCaisd3r9Xae4zc","https://ap.wps.com/l/cbCaisd3r9Xae4zc","pdf",3088321,"English","# Introduction: glioblastoma overview and challenges\n## Epidemiology and aetiology of GBM development\n## Tumour pathogenesis","[{\"question\":\"Why are effective GBM treatments difficult to achieve?\",\"answer\":\"Standard GBM therapy is largely ineffective at preventing recurrence, largely due to the immunosuppressive tumour microenvironment and the limited availability of tumour antigen-specific targets for immune therapies.\"},{\"question\":\"What is the role of MAIT cells in GBM immunity according to the review?\",\"answer\":\"MAIT cells are described as resident brain immune populations that may contribute to critical immune surveillance and diverse anti-tumour functions, making them candidates for immunotherapeutic targeting.\"},{\"question\":\"What does the review say about the evidence for MAIT cells in cancer?\",\"answer\":\"Findings on the role of MAIT cells in cancer are reported as conflicting, and many questions about MAIT–tumour cell interactions remain unresolved.\"}]","Unconventional guardians of the brain: MAIT cells as emerging players in glioblastoma immunity | PDF",1790097791,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7470cebd43caf319eda544c37073a349.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a672e1cf9fcf0974713c9b5021282416.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b3966b5b22a6a0a38630458e6552e4f.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/612caa6bedd44e40258db63256fedbcb.webp",980,1385]